News Focus
News Focus
icon url

DewDiligence

03/19/14 5:08 PM

#175709 RE: biotech jim #175685

The bear case for EVGN (such as it is) is that having collaborations will all of the leading ag-biotech companies (MON, DD, SYT) makes it hard to envision a buyout.